Madrigal Pharmaceuticals Inc (MDGL) — Tangible Net Worth Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Tangible Net Worth Ratio of 98.8% as of December 2025. This metric is calculated by deducting intangible assets ($7.38 Million) from net assets ($602.69 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See MDGL net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Madrigal Pharmaceuticals Inc Tangible Net Worth Ratio (2001–2025)
This chart shows how Madrigal Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 22 annual periods from 2001 to 2025. As of December 2025, the ratio stands at 98.8%, reflecting net assets of $602.69 Million with intangible assets of $7.38 Million USD. Also explore MDGL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Madrigal Pharmaceuticals Inc (2001–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Madrigal Pharmaceuticals Inc from 2001 to 2025, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Madrigal Pharmaceuticals Inc market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.8% | $602.69 Million | $7.38 Million | $1.26 Billion | ▼ -0.6 pp |
| 2024 | 99.4% | $754.38 Million | $4.73 Million | $1.04 Billion | ▼ -0.6 pp |
| 2023 | 100.0% | $405.33 Million | $0.00 | $640.55 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $197.39 Million | $0.00 | $362.57 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $196.11 Million | $0.00 | $273.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $239.97 Million | $0.00 | $287.00 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $416.56 Million | $0.00 | $442.06 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $476.98 Million | $0.00 | $485.43 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $182.26 Million | $0.00 | $192.31 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $36.41 Million | $0.00 | $41.21 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $50.41 Million | $0.00 | $68.19 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $65.14 Million | $0.00 | $100.67 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $49.09 Million | $0.00 | $95.20 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $75.07 Million | $0.00 | $103.02 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $14.77 Million | $0.00 | $42.32 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $23.48 Million | $0.00 | $54.07 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $24.91 Million | $0.00 | $48.91 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $24.90 Million | $0.00 | $122.65 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $52.48 Million | $0.00 | $71.21 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $117.96 Million | $0.00 | $132.02 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $76.89 Million | $0.00 | $80.39 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $2.74 Million | $0.00 | $2.77 Million | — |